Hakan Akilli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hakan Akilli has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
Mehmet Kayrak
Cardiology and
18 shared publications- Alpay Aribas
Department of Cardiology, Necmettin Erbakan University Meram School of Medicine, Meram, Konya, Turkey.
9 shared publications Kurtulus Ozdemir
Cardiology and
8 shared publicationsAlpay Aribas
Necmettin Erbakan University, Meram School of Medicine
7 shared publications- Sefa Tatar
Department of Cardiology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
7 shared publications Hajrudin Alibasic
Department of Cardiology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
5 shared publications
Latest Publications
- Open Access
- 22 June 2026
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 19 (1)
Left Ventricular Thrombus in Ischemic Heart Failure: Machine-learning–based Prediction of Six-month Persistence and One-year Outcomes
Left ventricular thrombus (LVT) in ischemic heart failure carries embolic risk; tools to anticipate persistence are limited. We studied 190 consecutive patients with imaging-confirmed LVT managed with guideline-concordant anticoagulation and serial echocardiography. The primary outcome was 6-month non-regression; 1-year MACE was secondary. We combined classical statistics with explainable machine learning. CatBoost yielded the best discrimination for non-regression (CV-AUC 0.76; test accuracy 0.79). SHAP highlighted left atrial diameter, pulmonary artery pressure, platelet count, and LV end-diastolic diameter as leading predictors. For 1-year outcomes, thrombus size and CHA2DS2-VA were independently associated with MACE (logistic AUC 0.71), whereas "regression vs persistence" alone was not. Baseline remodeling and coagulability markers, captured by an interpretable ML model, stratify early risk of LVT persistence and complement clinical decision-making for imaging follow-up and anticoagulation intensity.
- 22 June 2026
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 19 (1)
Open AccessLeft Ventricular Thrombus in Ischemic Heart Failure: Machine-learning–based Prediction of Six-month Persistence and One-year Outcomes
Left ventricular thrombus (LVT) in ischemic heart failure carries embolic risk; tools to anticipate persistence are limited. We studied 190 consecutive patients with imaging-confirmed LVT managed with guideline-concordant anticoagulation and serial echocardiography. The primary outcome was 6-month non-regression; 1-year MACE was secondary. We combined classical statistics with explainable machine learning. CatBoost yielded the best discrimination for non-regression (CV-AUC 0.76; test accuracy 0.79). SHAP highlighted left atrial diameter, pulmonary artery pressure, platelet count, and LV end-diastolic diameter as leading predictors. For 1-year outcomes, thrombus size and CHA2DS2-VA were independently associated with MACE (logistic AUC 0.71), whereas "regression vs persistence" alone was not. Baseline remodeling and coagulability markers, captured by an interpretable ML model, stratify early risk of LVT persistence and complement clinical decision-making for imaging follow-up and anticoagulation intensity.
- Open Access
- 18 May 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (2) , 153-156
Takotsubo Syndrome Presenting with Intrauterine Fetal Death in Late Pregnancy: A Diagnostic Challenge with Peripartum Cardiomyopathy
Peripartum cardiomyopathy (PPCM) is a major cause of heart failure in late pregnancy and the postpartum period, whereas takotsubo cardiomyopathy (TCM) is rare but may occur under severe stress. Differentiation between these conditions is challenging due to overlapping clinical features. A 30-year-old woman with an in vitro fertilization pregnancy presented at 34 weeks of gestation with dyspnea and intrauterine fetal demise. Echocardiography revealed severe left ventricular dysfunction (ejection fraction, 25%). Following surgical intervention and standard heart failure therapy, ventricular function improved rapidly, with the ejection fraction reaching 50% within one month. Despite pregnancy-related risk factors suggesting PPCM, the rapid recovery of left ventricular function favored a diagnosis of TCM. This case highlights the importance of careful clinical and imaging assessment and emphasizes that rapid ventricular recovery in late pregnancy should raise strong suspicion for TCM, even when classical PPCM risk factors coexist.
- 18 May 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (2) , 153-156
Open AccessTakotsubo Syndrome Presenting with Intrauterine Fetal Death in Late Pregnancy: A Diagnostic Challenge with Peripartum Cardiomyopathy
Peripartum cardiomyopathy (PPCM) is a major cause of heart failure in late pregnancy and the postpartum period, whereas takotsubo cardiomyopathy (TCM) is rare but may occur under severe stress. Differentiation between these conditions is challenging due to overlapping clinical features. A 30-year-old woman with an in vitro fertilization pregnancy presented at 34 weeks of gestation with dyspnea and intrauterine fetal demise. Echocardiography revealed severe left ventricular dysfunction (ejection fraction, 25%). Following surgical intervention and standard heart failure therapy, ventricular function improved rapidly, with the ejection fraction reaching 50% within one month. Despite pregnancy-related risk factors suggesting PPCM, the rapid recovery of left ventricular function favored a diagnosis of TCM. This case highlights the importance of careful clinical and imaging assessment and emphasizes that rapid ventricular recovery in late pregnancy should raise strong suspicion for TCM, even when classical PPCM risk factors coexist.
- Open Access
- 8 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
TAPSE/PAi, a practical echocardiographic functional–structural index, better reflects functional severity than TAPSE/sPAP in pulmonary hypertension
We evaluated TAPSE/PAi, defined as the ratio of tricuspid annular plane systolic excursion to the indexed main pulmonary artery diameter, as a pragmatic functional-structural index and compared it with TAPSE/sPAP. In this retrospective study, 53 patients with PAH were analyzed. Associations of TAPSE/PAi and TAPSE/sPAP with clinical, biomarker, and invasive hemodynamic variables were assessed. Discrimination for WHO-FC ≥ 3, 6MWD < 165 m, and PVR > 5 WU was evaluated by direction-aligned ROC analysis with Youden-optimal thresholds. Age- and sex-adjusted logistic regression models reported odds ratios (ORs) per 1-SD increase. TAPSE/PAi correlated more strongly than TAPSE/sPAP with WHO-FC (ρ=-0.592 vs. -0.384) and 6MWD (ρ = 0.493 vs. 0.378), whereas TAPSE/sPAP correlated more strongly with NT-proBNP/proBNP (ρ=-0.619 vs. -0.484) and with mPAP/PVR. TAPSE/PAi showed better discrimination for WHO-FC ≥ 3 and 6MWD < 165 m while TAPSE/sPAP performed modestly better for PVR > 5 WU The Youden-optimal TAPSE/PAi threshold was ≤ 1.296 for both WHO-FC ≥ 3 and 6MWD < 165 m. The higher TAPSE/PAi remained associated with lower odds of WHO-FC ≥ 3 and 6MWD < 165 m after age- and sex-adjustment. TAPSE/PAi better reflects functional severity and exercise limitation, whereas TAPSE/sPAP is more closely related to biomarker/hemodynamic burden. The indices appear complementary, and TAPSE/PAi may be a practical TR-independent severity marker in PAH.
- 8 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessTAPSE/PAi, a practical echocardiographic functional–structural index, better reflects functional severity than TAPSE/sPAP in pulmonary hypertension
We evaluated TAPSE/PAi, defined as the ratio of tricuspid annular plane systolic excursion to the indexed main pulmonary artery diameter, as a pragmatic functional-structural index and compared it with TAPSE/sPAP. In this retrospective study, 53 patients with PAH were analyzed. Associations of TAPSE/PAi and TAPSE/sPAP with clinical, biomarker, and invasive hemodynamic variables were assessed. Discrimination for WHO-FC ≥ 3, 6MWD < 165 m, and PVR > 5 WU was evaluated by direction-aligned ROC analysis with Youden-optimal thresholds. Age- and sex-adjusted logistic regression models reported odds ratios (ORs) per 1-SD increase. TAPSE/PAi correlated more strongly than TAPSE/sPAP with WHO-FC (ρ=-0.592 vs. -0.384) and 6MWD (ρ = 0.493 vs. 0.378), whereas TAPSE/sPAP correlated more strongly with NT-proBNP/proBNP (ρ=-0.619 vs. -0.484) and with mPAP/PVR. TAPSE/PAi showed better discrimination for WHO-FC ≥ 3 and 6MWD < 165 m while TAPSE/sPAP performed modestly better for PVR > 5 WU The Youden-optimal TAPSE/PAi threshold was ≤ 1.296 for both WHO-FC ≥ 3 and 6MWD < 165 m. The higher TAPSE/PAi remained associated with lower odds of WHO-FC ≥ 3 and 6MWD < 165 m after age- and sex-adjustment. TAPSE/PAi better reflects functional severity and exercise limitation, whereas TAPSE/sPAP is more closely related to biomarker/hemodynamic burden. The indices appear complementary, and TAPSE/PAi may be a practical TR-independent severity marker in PAH.
- Open Access
- 1 April 2026
- Published by The European Research Journal in The European Research Journal
- p. 488-500
Evaluation of Subclinical Cardiac Dysfunction in Rheumatoid Arthritis and Ankylosing Spondylitis Using Tissue Doppler Imaging: Impact of TNF-α Inhibitor Therapy
Objectives: This study aimed to evaluate left ventricular diastolic function in patients with rheumatoid arthritis and ankylosing spondylitis using the myocardial performance index derived from tissue Doppler imaging. A secondary objective was to assess whether tumor necrosis factor-alpha inhibitor therapy was associated with changes in cardiac performance. Methods: Patients diagnosed with rheumatoid arthritis or ankylosing spondylitis and age- and sex-matched healthy controls underwent comprehensive transthoracic echocardiography, including tissue Doppler imaging. The myocardial performance index was calculated using isovolumetric contraction time, isovolumetric relaxation time, and ejection time. Clinical disease activity and functional status were assessed. Subgroup analyses were conducted based on the use of tumor necrosis factor-alpha inhibitors. Results: Patients with rheumatoid arthritis exhibited significantly reduced early/atrial transmitral flow ratios in the lateral, anterior, and inferior walls of the left ventricle (P<0.05), as well as elevated pulmonary artery pressure (P=0.003), consistent with early diastolic dysfunction. Myocardial performance index values were regionally impaired. In contrast, patients with ankylosing spondylitis demonstrated preserved diastolic function with only a mild increase in pulmonary artery pressure (P=0.009). The use of tumor necrosis factor-alpha inhibitors was not significantly associated with differences in echocardiographic parameters. Conclusions: Subclinical diastolic dysfunction may be present in patients with rheumatoid arthritis even in the absence of overt cardiovascular disease. Diastolic indices appear preserved in ankylosing spondylitis. No significant echocardiographic differences were observed based on tumor necrosis factor-alpha inhibitor use, though further studies are warranted to clarify treatment-related effects.
- 1 April 2026
- Published by The European Research Journal in The European Research Journal
- p. 488-500
Open AccessEvaluation of Subclinical Cardiac Dysfunction in Rheumatoid Arthritis and Ankylosing Spondylitis Using Tissue Doppler Imaging: Impact of TNF-α Inhibitor Therapy
Objectives: This study aimed to evaluate left ventricular diastolic function in patients with rheumatoid arthritis and ankylosing spondylitis using the myocardial performance index derived from tissue Doppler imaging. A secondary objective was to assess whether tumor necrosis factor-alpha inhibitor therapy was associated with changes in cardiac performance. Methods: Patients diagnosed with rheumatoid arthritis or ankylosing spondylitis and age- and sex-matched healthy controls underwent comprehensive transthoracic echocardiography, including tissue Doppler imaging. The myocardial performance index was calculated using isovolumetric contraction time, isovolumetric relaxation time, and ejection time. Clinical disease activity and functional status were assessed. Subgroup analyses were conducted based on the use of tumor necrosis factor-alpha inhibitors. Results: Patients with rheumatoid arthritis exhibited significantly reduced early/atrial transmitral flow ratios in the lateral, anterior, and inferior walls of the left ventricle (P<0.05), as well as elevated pulmonary artery pressure (P=0.003), consistent with early diastolic dysfunction. Myocardial performance index values were regionally impaired. In contrast, patients with ankylosing spondylitis demonstrated preserved diastolic function with only a mild increase in pulmonary artery pressure (P=0.009). The use of tumor necrosis factor-alpha inhibitors was not significantly associated with differences in echocardiographic parameters. Conclusions: Subclinical diastolic dysfunction may be present in patients with rheumatoid arthritis even in the absence of overt cardiovascular disease. Diastolic indices appear preserved in ankylosing spondylitis. No significant echocardiographic differences were observed based on tumor necrosis factor-alpha inhibitor use, though further studies are warranted to clarify treatment-related effects.
- Open Access
- 4 November 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (4) , 679-689
Circulating organokines in coronary artery disease and metabolic syndrome: FABP4, adiponectin, irisin, FSTL1
Cardiovascular disorders are closely linked to metabolic syndrome and remain a leading cause of mortality worldwide, despite advances in early detection and treatment. Adipokines, cardiokines, and myokines play critical roles in maintaining systemic metabolic homeostasis. In this study, we measured serum levels of fatty acid binding protein 4 (FABP4), follistatin-like 1 (FSTL1), irisin, and adiponectin in 243 male patients undergoing elective coronary angiography. We investigated the associations of these biomarkers with coronary artery disease (CAD) and their correlation with metabolic syndrome status. FSTL1 levels were predicted using a Particle Swarm Optimization-enhanced Adaptive Neuro-Fuzzy Inference System (PSO-ANFIS) based on artificial intelligence. Patients with CAD exhibited significantly lower FABP4 levels (p<0.0001), and low FABP4 levels emerged as an independent predictor of CAD in logistic regression analysis (odds ratio 0.903, 95% CI 0.825-0.987, p=0.025). The combination of adiponectin, FSTL1, and irisin as a biomarker strategy demonstrated high sensitivity and specificity for diagnosing metabolic syndrome (AUC = 0.92, 95% CI 0.88-0.96). Both FSTL1 and adiponectin independently correlated with metabolic syndrome (p<0.001, odds ratio 1.039, 95% CI 1.025-1.054; p<0.001, odds ratio 0.979, 95% CI 0.971-0.988, respectively). The prediction of FSTL1 levels using PSO-ANFIS supports the concept of harmonization among metabolic messengers. These findings underscore the potential of FABP4 and FSTL1 as valuable biomarkers for diagnosing metabolic and cardiovascular diseases, thereby facilitating personalized interventions targeting organokine pathways.
- 4 November 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (4) , 679-689
Open AccessCirculating organokines in coronary artery disease and metabolic syndrome: FABP4, adiponectin, irisin, FSTL1
Cardiovascular disorders are closely linked to metabolic syndrome and remain a leading cause of mortality worldwide, despite advances in early detection and treatment. Adipokines, cardiokines, and myokines play critical roles in maintaining systemic metabolic homeostasis. In this study, we measured serum levels of fatty acid binding protein 4 (FABP4), follistatin-like 1 (FSTL1), irisin, and adiponectin in 243 male patients undergoing elective coronary angiography. We investigated the associations of these biomarkers with coronary artery disease (CAD) and their correlation with metabolic syndrome status. FSTL1 levels were predicted using a Particle Swarm Optimization-enhanced Adaptive Neuro-Fuzzy Inference System (PSO-ANFIS) based on artificial intelligence. Patients with CAD exhibited significantly lower FABP4 levels (p<0.0001), and low FABP4 levels emerged as an independent predictor of CAD in logistic regression analysis (odds ratio 0.903, 95% CI 0.825-0.987, p=0.025). The combination of adiponectin, FSTL1, and irisin as a biomarker strategy demonstrated high sensitivity and specificity for diagnosing metabolic syndrome (AUC = 0.92, 95% CI 0.88-0.96). Both FSTL1 and adiponectin independently correlated with metabolic syndrome (p<0.001, odds ratio 1.039, 95% CI 1.025-1.054; p<0.001, odds ratio 0.979, 95% CI 0.971-0.988, respectively). The prediction of FSTL1 levels using PSO-ANFIS supports the concept of harmonization among metabolic messengers. These findings underscore the potential of FABP4 and FSTL1 as valuable biomarkers for diagnosing metabolic and cardiovascular diseases, thereby facilitating personalized interventions targeting organokine pathways.
- Open Access
- 31 January 2024
- Published by Wiley
Is Diastolic Global Longitudinal Strain Rate Associated with Mortality and Re-hospitalization in Patients with Heart Failure?
Background: The aim of the present study was to investigate the association between diastolic global longitudinal strain (GLS) rateand mortality, re-hospitalization as well as hospitalization period in heart failure (HF) patients. Methods:Clinical, laboratory and echocardiographic parameters within the first 24 hours for 116 patients with ejection fraction (EF) ≤ 40% and Class 3 to Class 4 symptoms of New York Heart Association who were hospitalized in the cardiology clinic of our hospital were reviewed.Fiftyeight individuals without any diagnosis for cardiac failure were included as the control group. Echocardiographic measurements, tissue Doppler and diastolicstrain rate (SR) were reviewed. The N-terminal pro-brainnatriuretic peptide (ProBNP)level was analysed in addition to standard biochemical and hematological parameters. Results: The diastolic E strain rate and E/E’SR was statistically significant in patients with mortality within one month (p<0.05). These two parameters were statistically significant also in patients with one-month mortality (p <0.005).When looked under the guidance of these findings, E strain rate and E / E ’SR are a predictive parameter for one month mortality in HF patients. Conclusion: The E strain rate and E/E’SR are superior parameters than other tissue doppler parameters to predict the prognosis and the mortality in patients with heart failure. E/E’SR is a superior indicator for diastolic function of thre left ventricle when compared to other tissue doppler parameters.
- 31 January 2024
- Published by Wiley
Open AccessIs Diastolic Global Longitudinal Strain Rate Associated with Mortality and Re-hospitalization in Patients with Heart Failure?
Background: The aim of the present study was to investigate the association between diastolic global longitudinal strain (GLS) rateand mortality, re-hospitalization as well as hospitalization period in heart failure (HF) patients. Methods:Clinical, laboratory and echocardiographic parameters within the first 24 hours for 116 patients with ejection fraction (EF) ≤ 40% and Class 3 to Class 4 symptoms of New York Heart Association who were hospitalized in the cardiology clinic of our hospital were reviewed.Fiftyeight individuals without any diagnosis for cardiac failure were included as the control group. Echocardiographic measurements, tissue Doppler and diastolicstrain rate (SR) were reviewed. The N-terminal pro-brainnatriuretic peptide (ProBNP)level was analysed in addition to standard biochemical and hematological parameters. Results: The diastolic E strain rate and E/E’SR was statistically significant in patients with mortality within one month (p<0.05). These two parameters were statistically significant also in patients with one-month mortality (p <0.005).When looked under the guidance of these findings, E strain rate and E / E ’SR are a predictive parameter for one month mortality in HF patients. Conclusion: The E strain rate and E/E’SR are superior parameters than other tissue doppler parameters to predict the prognosis and the mortality in patients with heart failure. E/E’SR is a superior indicator for diastolic function of thre left ventricle when compared to other tissue doppler parameters.
- Open Access
- 1 August 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (8) , 1124-1129
Prognostic nutritional index and the risk of acute kidney injury in patients with acute coronary syndrome
Recent studies have linked malnutrition with undesirable outcomes in cardiovascular diseases. However, the underlying mechanism is unknown. Contrast-induced acute kidney injury (CI-AKI) increased cardiovascular mortality after percutaneous coronary intervention (PCI). This study hypothesizes that prognostic nutritional index (PNI) plays a role in the development of CI-AKI in patients with acute coronary syndrome undergoing emergency PCI. This study enrolled 551 patients. PNI was determined as 10× serum albumin (g/dL)+0.005×total lymphocyte count (mm3). CI-AKI was characterized as the increase in serum creatinine ≥0.3 mg/dL level within 48 h after PCI. Patients were classified as either CI-AKI (+) or CI-AKI (-). CI-AKI has occurred in 72 of 551 patients (13.1%). PNI was significantly lower in the CI-AKI (+) group than in the CI-AKI (-) group (44.4±6.6 versus 47.2±5.8, p<0.001, respectively). Multivariate logistic regression analysis showed that PNI [odds ratio, OR: 1.631, 95% confidence interval (CI): 1.168-2.308, p=0.02] and estimated glomerular filtration rate (OR: 3.26, 95%CI 1.733-6.143, p<0.001) were independent risk factors for CI-AKI. PNI is an independent risk factor for CI-AKI. The development of CI-AKI may be the mechanism responsible for the relationship between poor nutritional status and adverse cardiac events.
- 1 August 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (8) , 1124-1129
Open AccessPrognostic nutritional index and the risk of acute kidney injury in patients with acute coronary syndrome
Recent studies have linked malnutrition with undesirable outcomes in cardiovascular diseases. However, the underlying mechanism is unknown. Contrast-induced acute kidney injury (CI-AKI) increased cardiovascular mortality after percutaneous coronary intervention (PCI). This study hypothesizes that prognostic nutritional index (PNI) plays a role in the development of CI-AKI in patients with acute coronary syndrome undergoing emergency PCI. This study enrolled 551 patients. PNI was determined as 10× serum albumin (g/dL)+0.005×total lymphocyte count (mm3). CI-AKI was characterized as the increase in serum creatinine ≥0.3 mg/dL level within 48 h after PCI. Patients were classified as either CI-AKI (+) or CI-AKI (-). CI-AKI has occurred in 72 of 551 patients (13.1%). PNI was significantly lower in the CI-AKI (+) group than in the CI-AKI (-) group (44.4±6.6 versus 47.2±5.8, p<0.001, respectively). Multivariate logistic regression analysis showed that PNI [odds ratio, OR: 1.631, 95% confidence interval (CI): 1.168-2.308, p=0.02] and estimated glomerular filtration rate (OR: 3.26, 95%CI 1.733-6.143, p<0.001) were independent risk factors for CI-AKI. PNI is an independent risk factor for CI-AKI. The development of CI-AKI may be the mechanism responsible for the relationship between poor nutritional status and adverse cardiac events.
- 28 December 2020
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 11 (4) , 101-103
Is Computed Tomography the Gold Standard in Aortic Dissection?
İntroduction: Aortic dissection is a disease with high mortality, which is characterized by a tear in the aortic wall. Thanks to early diagnosis and treatment, patients' survival rates are high. Chest pain is the most common symptom. Imaging methods help in diagnosis. Its treatment is surgery. Case report: A 47-year-old male patient was admitted to the emergency department with chest pain. The diagnosis of aortic dissection in computed tomography was evaluated as motion artifact and valve motion, and he was asked to be discharged from the emergency service after his diagnosis was missed. However, transesophageal echocardiography was performed because of the patient's clinical symptom and echocardiographic findings supported the aortic dissection. When a dissection flap was seen in transesophageal echocardiography, the patient was transferred to surgery. In surgery, a dacron graft was placed in the patient's aorta and a prosthetic valve was placed on the aortic valve, and left main coronary repair and right coronary is bypass were performed. The patient was discharged without any problem. Conclusion: Aortic dissection is a clinical diagnosis, it is a disease with high mortality. Imaging methods are helpful in diagnosis, but the fact that imaging methods rule out dissection does not always rule out the disease. The important thing is to suspect the disease and to consider the patient's current clinical symptoms and signs.
- 28 December 2020
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 11 (4) , 101-103
Is Computed Tomography the Gold Standard in Aortic Dissection?
İntroduction: Aortic dissection is a disease with high mortality, which is characterized by a tear in the aortic wall. Thanks to early diagnosis and treatment, patients' survival rates are high. Chest pain is the most common symptom. Imaging methods help in diagnosis. Its treatment is surgery. Case report: A 47-year-old male patient was admitted to the emergency department with chest pain. The diagnosis of aortic dissection in computed tomography was evaluated as motion artifact and valve motion, and he was asked to be discharged from the emergency service after his diagnosis was missed. However, transesophageal echocardiography was performed because of the patient's clinical symptom and echocardiographic findings supported the aortic dissection. When a dissection flap was seen in transesophageal echocardiography, the patient was transferred to surgery. In surgery, a dacron graft was placed in the patient's aorta and a prosthetic valve was placed on the aortic valve, and left main coronary repair and right coronary is bypass were performed. The patient was discharged without any problem. Conclusion: Aortic dissection is a clinical diagnosis, it is a disease with high mortality. Imaging methods are helpful in diagnosis, but the fact that imaging methods rule out dissection does not always rule out the disease. The important thing is to suspect the disease and to consider the patient's current clinical symptoms and signs.
- 28 December 2020
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 11 (4) , 104-107
Two-edged Knife: Massive Pulmonary Embolism and Thrombolytic Contraindication
İntroduction: Pulmonary embolism is a common cause of death among emergency department admissions, and it has a high mortality and morbidity rate. Etiological reasons are generally associated with immobility. Radiological imaging methods are at the forefront in diagnosis. Anticoagulant and thrombolytic therapy may be preferred in treatment according to the hemodynamic condition of the patient. Case report: A 56-year-old female patient admitted to the emergency department with sudden onset of dyspnea and syncope with a condition of cardiogenic shock, and echocardiography revealed an enlargement of the right heart chambers and impaired functions, and a tomography was performed with the pre-diagnosis of pulmonary embolism. When systemic thrombolytic therapy was contraindicated in the patient who had embolism on tomography, catheter-based thrombectomy and selective low-dose thrombolytic therapy to the pulmonary artery were administered. The patient, who became hemodynamically stable and his shock condition improved, was discharged with anticoagulant therapy. Conclusion: When left untreated, pulmonary embolism is a disease with a high mortality rate. Although systemic thrombolytic treatments are contraindicated in some patients, successful results can be obtained with locally effective interventional treatments in these patient groups. Keywords: Pulmonary embolism, catheter-based thrombolysis, thrombolytic therapy
- 28 December 2020
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 11 (4) , 104-107
Two-edged Knife: Massive Pulmonary Embolism and Thrombolytic Contraindication
İntroduction: Pulmonary embolism is a common cause of death among emergency department admissions, and it has a high mortality and morbidity rate. Etiological reasons are generally associated with immobility. Radiological imaging methods are at the forefront in diagnosis. Anticoagulant and thrombolytic therapy may be preferred in treatment according to the hemodynamic condition of the patient. Case report: A 56-year-old female patient admitted to the emergency department with sudden onset of dyspnea and syncope with a condition of cardiogenic shock, and echocardiography revealed an enlargement of the right heart chambers and impaired functions, and a tomography was performed with the pre-diagnosis of pulmonary embolism. When systemic thrombolytic therapy was contraindicated in the patient who had embolism on tomography, catheter-based thrombectomy and selective low-dose thrombolytic therapy to the pulmonary artery were administered. The patient, who became hemodynamically stable and his shock condition improved, was discharged with anticoagulant therapy. Conclusion: When left untreated, pulmonary embolism is a disease with a high mortality rate. Although systemic thrombolytic treatments are contraindicated in some patients, successful results can be obtained with locally effective interventional treatments in these patient groups. Keywords: Pulmonary embolism, catheter-based thrombolysis, thrombolytic therapy
- Open Access
- 1 December 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (12) , 1657-1665
Index of cardiac-electrophysiological balance and the effects of thrombolytic therapy on the electrocardiogram of patients with pulmonary embolism
SUMMARY OBJECTIVE: Different parameters on electrocardiograms (ECG) have been investigated to predict arrhythmia and mortality in patients with acute pulmonary embolism (APE). The acute effect of thrombolytic therapy (TT) on these parameters has not been investigated yet. METHODS: We examined the data of 83 patients who were evaluated as high-risk APE and discharged from the hospital after TT. First, the high-risk APE patients’ ECGs were compared with healthy control subjects (n = 55). After their admission and 24 hours later, the ECGs of patients with APE were compared. Heart rate, P-wave morphology, QRS duration, QT distance, Tp-e, and the index of cardiac electrophysiological balance (iCEB) were analyzed. RESULTS: Although P maximum was not different between the groups’ ECGs, heart rate, QT, QTc (corrected QT) interval, Tp-e intervals, Tp-e/QT ratio, and P wave dispersion were significantly higher in the APE group ( P values < 0.031). iCEB or iCEBc (corrected iCEB) values were lower in APE group ( P < 0.001). After TT, we determined a decrease in heart rate, Tp-e interval, and Tp-e/QT ratio ( P < 0.001). Although we detected a decrease in the QT and QTc interval and QT dispersion (QTd), QTd had no statistical significance (respectively P -value 0.013, 0.029, and 0.096). The iCEB and iCEBc levels were lower after TT ( P -value was 0.035 and 0.044 respectively). CONCLUSION: The QT, QTc, Tp-e interval, Tp-e/QTc ratio, iCEB, and iCEBc values significantly decreased after TT. It may be thought that effective TT causes partial improvement in ventricular repolarization in an early period.
- 1 December 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (12) , 1657-1665
Open AccessIndex of cardiac-electrophysiological balance and the effects of thrombolytic therapy on the electrocardiogram of patients with pulmonary embolism
SUMMARY OBJECTIVE: Different parameters on electrocardiograms (ECG) have been investigated to predict arrhythmia and mortality in patients with acute pulmonary embolism (APE). The acute effect of thrombolytic therapy (TT) on these parameters has not been investigated yet. METHODS: We examined the data of 83 patients who were evaluated as high-risk APE and discharged from the hospital after TT. First, the high-risk APE patients’ ECGs were compared with healthy control subjects (n = 55). After their admission and 24 hours later, the ECGs of patients with APE were compared. Heart rate, P-wave morphology, QRS duration, QT distance, Tp-e, and the index of cardiac electrophysiological balance (iCEB) were analyzed. RESULTS: Although P maximum was not different between the groups’ ECGs, heart rate, QT, QTc (corrected QT) interval, Tp-e intervals, Tp-e/QT ratio, and P wave dispersion were significantly higher in the APE group ( P values < 0.031). iCEB or iCEBc (corrected iCEB) values were lower in APE group ( P < 0.001). After TT, we determined a decrease in heart rate, Tp-e interval, and Tp-e/QT ratio ( P < 0.001). Although we detected a decrease in the QT and QTc interval and QT dispersion (QTd), QTd had no statistical significance (respectively P -value 0.013, 0.029, and 0.096). The iCEB and iCEBc levels were lower after TT ( P -value was 0.035 and 0.044 respectively). CONCLUSION: The QT, QTc, Tp-e interval, Tp-e/QTc ratio, iCEB, and iCEBc values significantly decreased after TT. It may be thought that effective TT causes partial improvement in ventricular repolarization in an early period.